Giannini G.; Marzi M.; Pezzi R.; Brunetti T.; Battistuzzi G.; Marzo M.D.; Cabri W.; Vesci L.; Pisano C., Corrigendum to "N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors" [Bioorg. Med. Chem. Lett. 19 (2009) 2346] (DOI:10.1016/j.bmcl.2009.02.029), «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2009, 19, pp. 3694 - 3694 [articolo]
Brevetto n. US8865597, Crystalline(6R,7R)-7-[1,2,4]triazolo-3-yl)-2-[(Z)-trityloxyimino]-acety-lamino)- 3-[(R)-1’-tert-butoxycarbonyl-2-oxo-[1,3’]bipyrrolidinyl-(3E)ylidenemethyl-8-oxo- 5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydril ester; its manufacturing and use.
Brevetto n. WO2009109504, Enol carbamate derivatives as modulators of fatty Acid Amide Hydrolase.
Giannini G; Marzi M; Di Marzo M; Battistuzzi G; Pezzi R; Brunetti T; Cabri W; Vesci L; Pisano C, Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2009, 19, pp. 2840 - 2843 [articolo]
Giannini G; Marzi M; Pezzi R; Brunetti T; Battistuzzi G; Di Marzo M; Cabri W; Vesci L; Pisano C, N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2009, 19, pp. 2346 - 2349 [replica/breve intervento]
Brevetto n. WO2009138416, OXIME CARBAMOYL DERIVATIVES AS MODULATORS OF FATTY ACID AMIDES HYDROLASE.
Brevetto n. US8664210, Aminooxime derivatives of 2 and/or 4 substitued androstanes and androstenes as medicaments for cardiovascular disorders.
Brevetto n. US8598384, Crystalline Teglicar.
Giannini G; Marzi M; Cabri W; Marastoni E; Battistuzzi G; Vesci L; Pisano C; Beretta GL; De Cesare M; Zunino F, E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2008, 18, pp. 2910 - 2915 [replica/breve intervento]
Cabri W, Industrial Synthesis Design With Low Environmental Impact In The Pharma Industry, in: New Methodologies and Techniques for a Sustainable Organic Chemistry, DEU, Springer-Verlag, 2008, pp. 119 - 129 [capitolo di libro]
Brevetto n. US8269007, New cristalline form of 7-dimethoxymethylcamptothecin.
Tassoni E; Giannessi F; Brunetti T; Pessotto P; Renzulli M; Travagli M; Rajamaki S; Prati S; Dottori S; Corelli F; Cabri W; Carminati P; Botta M, Novel substituted aminoalkylguanidines as potential antihyperglycemic and food intake-reducing agents, «JOURNAL OF MEDICINAL CHEMISTRY», 2008, 51, pp. 3073 - 3076 [articolo]
Cabri W; Ciogli A; D'Acquarica I; Di Mattia M; Galletti B; Gasparrini F; Giorgi F; Lalli S; Pierini M; Simone P, On-column epimerization of dihydroartemisinin: An effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph, «JOURNAL OF CHROMATOGRAPHY. B», 2008, 875, pp. 180 - 191 [articolo]
Cabri W, Polymorphism, Patent and Legal Battles: Science or Fiction?, in: Seminars in Organic Synthesis, roma, Societa Chimica Italiana; Divisione di Chimica Organica, 2008, pp. 127 - 157 [commento giuridico]
Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C, Synthesis and biological activity of fluorinated combretastatin analogues, «JOURNAL OF MEDICINAL CHEMISTRY», 2008, 51, pp. 2708 - 2721 [articolo]
